Skip to Content
Discovering the causes of cancer and the means of prevention

Jill Koshiol, Ph.D.

Earl Stadtman Investigator

Information for Journalists

To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:


Phone: 240-760-6600

Spotlight on Investigator

Read Jill Koshiol's profile (pdf) in the November 2010 Linkage newsletter.

Jill Koshiol, Ph.D.

Jill Koshiol, Ph.D.

Organization:National Cancer Institute
Division of Cancer Epidemiology & Genetics, Infections and Immunoepidemiology Branch
Address:NCI Shady Grove
Room 6E212


Dr. Jill Koshiol received her Ph.D. in epidemiology from the University of North Carolina at Chapel Hill School of Public Health in 2005. Subsequently, she joined the Genetic Epidemiology Branch of the Division of Cancer Epidemiology and Genetics as a Cancer Prevention Fellow. There, she focused on the role of human papillomavirus (HPV) in upper gastrointestinal and lung cancer, as well as infection- and immune-related conditions in lung and hematopoietic cancers. Dr. Koshiol joined the Infections and Immunoepidemiology Branch as a Research Fellow in 2008 and became an Earl Stadtman Tenure-Track Investigator in 2010.

Research Interests

In addition to her continued interest in investigating the epidemiology of infectious agents and cancer, Dr. Koshiol is increasingly interested in the role of immune stimulation and inflammation in carcinogenesis. Infection elicits inflammatory and other immune responses. Measuring infection and immune and inflammatory responses in biological specimens can provide novel insights into carcinogenesis, identify molecular subtypes of cancer, and identify potential associations with cancer outcomes.

Given her interest in immune response and carcinogenesis, Dr. Koshiol has recently focused her research program on hepatobiliary cancers, which are linked to both infections and inflammation. Dr. Koshiol is the Principal Investigator for the Shanghai Biliary Tract Cancer Study and leads the Chile Gallbladder Cancer Pilot Study. Using these studies and others, she plans to evaluate the role of immune response and inflammation in hepatobiliary cancers to elucidate etiologic mechanisms and aid cancer prevention through the identification of cancer-related molecular pathways and targets.